CINXE.COM

<!DOCTYPE html> <html> <head> <meta charset="utf-8"> <meta name="robots" content="index,follow" /> <meta name="author" content="Neofema s.r.o." /> <meta name="keywords" content="Inovace pro život " /> <meta name="description" content="The aim of the study “Innovation for Life” is to emphasize the impact of innovations on healthcare in the Czech Republic and to provide verified data ..." /> <title>STUDY - Inovace pro život </title> <link href="/templates/custom_leky/css/jquery.rateyo.min.css" rel="stylesheet" type="text/css" /> <link href="/templates/custom_leky/style.min.css?v=7" rel="stylesheet" type="text/css" /> <link href="/templates/custom_leky/css/swiper.min.css" rel="stylesheet"> <link href="/templates/custom_leky/css/jquery.fancybox.min.css" rel="stylesheet"> <meta name="viewport" content=" width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=1"/> <meta name="google-site-verification" content="RQNNUXlwRbipT8plrsqmRx2tUYrZD1zLyr4Ah5EtN0E" /> <meta property="og:title" content="STUDY" /> <meta property="og:description" content="The aim of the study “Innovation for Life” is to emphasize the impact of innovations on healthcare in the Czech Republic and to provide verified data ..." /> <meta property="og:url" content="https://inovaceprozivot.cz/en/study/" /> <meta property="og:image" content="https://inovaceprozivot.cz/templates/custom_leky/img/defsharefb.jpg" /> <meta property="og:image:secure_url" content="https://inovaceprozivot.cz/templates/custom_leky/img/defsharefb.jpg" /> <link rel="apple-touch-icon" sizes="57x57" href="/templates/custom_leky/fav/apple-icon-57x57.png"> <link rel="apple-touch-icon" sizes="60x60" href="/templates/custom_leky/fav/apple-icon-60x60.png"> <link rel="apple-touch-icon" sizes="72x72" href="/templates/custom_leky/fav/apple-icon-72x72.png"> <link rel="apple-touch-icon" sizes="76x76" href="/templates/custom_leky/fav/apple-icon-76x76.png"> <link rel="apple-touch-icon" sizes="114x114" href="/templates/custom_leky/fav/apple-icon-114x114.png"> <link rel="apple-touch-icon" sizes="120x120" href="/templates/custom_leky/fav/apple-icon-120x120.png"> <link rel="apple-touch-icon" sizes="144x144" href="/templates/custom_leky/fav/apple-icon-144x144.png"> <link rel="apple-touch-icon" sizes="152x152" href="/templates/custom_leky/fav/apple-icon-152x152.png"> <link rel="apple-touch-icon" sizes="180x180" href="/templates/custom_leky/fav/apple-icon-180x180.png"> <link rel="icon" type="image/png" sizes="192x192" href="/templates/custom_leky/fav/android-icon-192x192.png"> <link rel="icon" type="image/png" sizes="32x32" href="/templates/custom_leky/fav/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="96x96" href="/templates/custom_leky/fav/favicon-96x96.png"> <link rel="icon" type="image/png" sizes="16x16" href="/templates/custom_leky/fav/favicon-16x16.png"> <link rel="manifest" href="/templates/custom_leky/fav/manifest.json"> <meta name="msapplication-TileColor" content="#ffffff"> <meta name="msapplication-TileImage" content="/templates/custom_leky/fav/ms-icon-144x144.png"> <meta name="theme-color" content="#ffffff"> <script type="text/javascript">var LANG="en";</script>  <script src="https://cdn.cookiehub.eu/c2/fee92ffd.js"></script> <script type="text/javascript"> document.addEventListener("DOMContentLoaded", function(event) { var cpm = {}; window.cookiehub.load(cpm); }); </script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WM5G3QS');</script>  </head> <body>  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WM5G3QS" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <div id="wrapper"> <header> <div class="headerTop"> <div class="grid-container"> <a class="logo" href="/en/"></a> <button class="showMenu" data-toggle="#menu"><span></span><span></span><span></span></button> <nav id="menu" class="hidden"> <div class="menuBasic"> <ul> <li><a href="/en/power-of-innovations/">POWER OF INNOVATIONS</a></li> <li><a href="/en/economic-impact/">ECONOMIC IMPACT</a></li> <li><a href="/en/study/">STUDY</a></li> <li> <a href="/en/"> <img alt="" src="data:image/svg+xml,%3Csvg%20width%3D%2285px%22%20height%3D%2285px%22%20viewBox%3D%220%200%20170.08%20170.08%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Cstyle%20type%3D%22text%2Fcss%22%3E.st0%7Bfill%3A%23ffffff%3B%7D.st1%7Bfill%3Aurl%28%23SVGID_1_%29%3B%7D%3C%2Fstyle%3E%3Cg%3E%3Cg%3E%3Cpath%20class%3D%22st0%22%20d%3D%22M120.47%2C77.59c0-1.6-0.21-3.26-0.64-4.98c-1.78-7.11-6.4-11.87-13.52-13.85c-7.03-1.95-13.34-0.31-18.71%2C4.63c-0.43%2C0.39-0.81%2C0.84-1.19%2C1.32c-0.41%2C0.38-0.86%2C0.81-1.39%2C1.31c-0.54-0.51-0.98-0.93-1.39-1.31c-0.38-0.48-0.76-0.93-1.19-1.32c-5.37-4.94-11.69-6.58-18.71-4.63C56.6%2C60.74%2C51.97%2C65.5%2C50.2%2C72.61c-1.86%2C7.45%2C0.36%2C13.87%2C6%2C19.09c0.54%2C0.5%2C1.08%2C1%2C1.62%2C1.5c1.54%2C1.46%2C2.94%2C2.79%2C4.35%2C4.09c6.76%2C6.27%2C13.53%2C12.55%2C20.3%2C18.81c1.08%2C1%2C1.81%2C1.48%2C2.54%2C1.45c0.73%2C0.02%2C1.46-0.45%2C2.54-1.45c4.11-3.8%2C11.04-10.33%2C15.15-14.14l0%2C0c0.44-0.43%2C0.7-1.03%2C0.7-1.68c0-1.32-1.07-2.38-2.39-2.38c-0.69%2C0-1.31%2C0.29-1.75%2C0.76c-3.41%2C3.17-9.59%2C9-12.96%2C12.16c-0.5%2C0.47-0.9%2C0.71-1.29%2C0.74c-0.39-0.03-0.79-0.27-1.29-0.74C70.63%2C98.53%2C62.68%2C91.27%2C58.91%2C87.74c-3.75-3.51-5.26-7.97-4.35-12.97c1.03-5.7%2C4.47-9.68%2C10.07-11.4c2.03-0.62%2C3.99-0.85%2C5.87-0.69c3.11%2C0.36%2C6.1%2C1.72%2C8.59%2C4.06c1.31%2C1.23%2C2.55%2C2.55%2C3.86%2C3.79c0.77%2C0.74%2C1.42%2C1.09%2C2.06%2C1.07c0.64%2C0.02%2C1.29-0.33%2C2.06-1.07c1.31-1.24%2C2.54-2.56%2C3.86-3.79c2.49-2.34%2C5.48-3.71%2C8.59-4.06c1.87-0.16%2C3.83%2C0.07%2C5.87%2C0.69c5.61%2C1.72%2C9.04%2C5.7%2C10.07%2C11.4c0.17%2C0.93%2C0.25%2C1.84%2C0.25%2C2.73c-0.04%2C0.16-0.06%2C0.32-0.07%2C0.48c-0.18%2C3.75-3.14%2C6.87-6.85%2C7.47l-6.58-11.94c-0.42-0.76-1.22-1.24-2.1-1.26c-0.87-0.02-1.69%2C0.43-2.14%2C1.18L85.8%2C93.59l-3.83-6.79c-0.43-0.77-1.25-1.24-2.13-1.24h-7.68c-1.35%2C0-2.44%2C1.09-2.44%2C2.43c0%2C1.34%2C1.09%2C2.43%2C2.44%2C2.43h6.24l5.19%2C9.2c0.43%2C0.76%2C1.22%2C1.23%2C2.1%2C1.24c0.01%2C0%2C0.03%2C0%2C0.04%2C0c0.86%2C0%2C1.65-0.45%2C2.1-1.18l12.14-20.12l5.28%2C9.59c0.43%2C0.78%2C1.25%2C1.26%2C2.14%2C1.26h0.1c3.38%2C0%2C6.59-1.28%2C9.04-3.6c2.42-2.3%2C3.83-5.35%2C3.99-8.6C120.53%2C78%2C120.51%2C77.79%2C120.47%2C77.59%22%2F%3E%3C%2Fg%3E%3C%2Fg%3E%3Cg%3E%3ClinearGradient%20id%3D%22SVGID_1_%22%20gradientUnits%3D%22userSpaceOnUse%22%20x1%3D%22-95.4334%22%20y1%3D%22268.3503%22%20x2%3D%22-93.516%22%20y2%3D%22268.3503%22%20gradientTransform%3D%22matrix%2867.3973%2062.4106%2062.4106%20-67.3973%20-10292.8799%2024069.791%29%22%3E%3Cstop%20offset%3D%220%22%20style%3D%22stop-color%3A%23E2C329%22%2F%3E%3Cstop%20offset%3D%220.2418%22%20style%3D%22stop-color%3A%23C6D45D%22%2F%3E%3Cstop%20offset%3D%220.5118%22%20style%3D%22stop-color%3A%239DC01C%22%2F%3E%3Cstop%20offset%3D%220.776%22%20style%3D%22stop-color%3A%2393D5F6%22%2F%3E%3Cstop%20offset%3D%221%22%20style%3D%22stop-color%3A%23006EAA%22%2F%3E%3C%2FlinearGradient%3E%3Cpath%20class%3D%22st1%22%20d%3D%22M134.45%2C85.04l1.92%2C0c-0.05%2C28.32-22.99%2C51.27-51.33%2C51.33h0h0c-28.34-0.06-51.28-23.01-51.33-51.33l0%2C0l0%2C0c0.05-28.32%2C22.99-51.27%2C51.33-51.33l0.01%2C0h0c28.34%2C0.06%2C51.28%2C23.01%2C51.33%2C51.33v0v0L134.45%2C85.04l-1.92%2C0c-0.05-26.23-21.29-47.46-47.49-47.51h0.01c-26.2%2C0.05-47.44%2C21.29-47.49%2C47.51v-0.01c0.05%2C26.23%2C21.29%2C47.46%2C47.49%2C47.51h-0.01c26.2-0.05%2C47.44-21.29%2C47.49-47.51v0.01L134.45%2C85.04z%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E" /> </a> </li> <li><a href="/en/treatment-progress/">TREATMENT PROGRESS</a></li> <li><a href="/en/development-potential/">DEVELOPMENT POTENTIAL</a></li> <li><a href="/en/contact/">Contact</a></li> </ul> </div> </nav> <div class="lang"> <a href="/cs/studie/" title="čeština"><img src="/templates/custom_leky/img/flag_cs.png" alt="čeština" /></a> <a href="/en/study/" title="english"><img src="/templates/custom_leky/img/flag_en.png" alt="english" /></a> </div> </div> </div> <section id="motiveWrap"> <div class="grid-container"> <h1>STUDY</h1> </div> </section> </header> <main class="main"> <div class="grid-container"> <p style="text-align: justify;"><span style="font-size: 18px;"><em><strong>The aim of the study “Innovation for Life” is to emphasize the impact of innovations on healthcare in the Czech Republic and to provide verified data about innovative treatment to all stakeholders. Together with the consulting company EY and many experts, we have therefore mapped and quantified the impact of innovative treatment on patients' lives, the health and social security system and the Czech economy. </strong></em></span></p> </div> </main> <section class="expression textCenter"> <div class="grid-container"> <p style="text-align: justify;"><em>&bdquo;Medicinal products cannot be seen as a one-off expense, but rather as an investment. It is important to have a realistic view of the whole spectrum of expenses - not only healthcare expenses, but especially expenses in terms of the social security budget and pension insurance,”</em> says Mgr. Jakub Dvořáček, MHA, executive director of the Association of Innovative Pharmaceutical Industry (AIFP).  </p> <h3 style="text-align: left;">Nine therapeutic areas</h3> <p style="text-align: justify;">The study “Innovation for Life” focused on 9 therapeutic areas that show the challenges and illustrate the development and progress of innovative treatment with a quantifiable impact. Selected diseases were defined based on precisely given criteria. These are mostly areas with relatively high morbidity, prevalence and incidence in the Czech Republic.<br />  <br />Multiple sclerosis is one of the diseases that the study focused on. Innovative medicinal products, along with early diagnosis, not only prolong life expectancy, stop the progression of the disease and make it possible for patients to return to work sooner but also save healthcare and social security budget funds. “In 2010-2017, the state saved at least 560 million Czech Crowns just on shorter hospitalizations and a lower number of disability pensions. The study has discovered similar savings in other areas of treatment as well. We must be able to calculate the impact of innovative treatment since it represents rather large sums,” says Jakub Dvořáček.</p> <h3 style="text-align: left;"><span style="font-size: 18px;">Read more about the benefits in specific therapeutic areas: </span></h3> <ul> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/type-2-diabetes-mellitus/" target="_blank" rel="noopener">Type 2 diabetes mellitus</a> </span></li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/prostate-cancer/" target="_blank" rel="noopener">Prostate cancer</a>   </span></li> <li style="text-align: left;"><a href="https://inovaceprozivot.cz/en/treatment-progress/breast-cancer/" target="_blank" rel="noopener">Breast cancer</a> </li> <li style="text-align: left;"><a href="https://inovaceprozivot.cz/en/treatment-progress/colorectal-cancer/" target="_blank" rel="noopener">Colorectal cancer</a>     </li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/chronic-myeloid-leukemia/" target="_blank" rel="noopener">Chronic myeloid leukemia</a>   </span></li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/chronic-obstructive-pulmonary-disease/" target="_blank" rel="noopener">Chronic obstructive pulmonary disease</a> </span></li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/rheumatoid-arthritis/" target="_blank" rel="noopener">Rheumatoid arthritis</a>  </span></li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/multiple-sclerosis/" target="_blank" rel="noopener">Multiple sclerosis</a> </span></li> <li style="text-align: left;"><span><a href="https://inovaceprozivot.cz/en/treatment-progress/idiopathic-intestinal-inflammation/" target="_blank" rel="noopener">Idiopathic intestinal inflammation</a>  </span></li> </ul> <h3 style="text-align: left;">The entire system profits from innovative medicinal products</h3> <p style="text-align: justify;">The study also looked at <strong>the economic benefits of the innovative industry</strong>. The pharmaceutical industry generates significant funds and a turnover with a relatively high multiplier effect through its activities and investments. <strong>The economic impact</strong> increased from 25 billion Czech Crowns in 2009 to <strong>42 billion Czech Crowns</strong> in 2018. Every Czech Crown spent by AIFP generates an additional 2.4 Czech Crowns in the national economy.    <br /> <br /><em>&bdquo;The social security budget benefits e.g. from disability pension savings and the healthcare budget from shorter hospitalizations. From a macroeconomic point of view, the innovative industry brings a high added value. The study has shown that innovative medicinal products represent an investment that pays off in the long run,"</em> says Jakub Dvořáček.</p> <h3 style="text-align: left;">Respected experts and valid data</h3> <p style="text-align: left;"><strong>The co-author of the study is the consulting company EY.</strong> The following experts also collaborated on the study:</p> <ul> <li style="text-align: left;">Ing. Miroslav Zámečník, support and validation of economic impact calculation;</li> <li style="text-align: left;">prof. RNDr. Ladislav Du&scaron;ek, Ph.D., calculation and validation of the demographic impact;</li> <li style="text-align: left;">Rut Bízková, support and validation of innovative challenges and opportunities;</li> <li style="text-align: left;">AIFP member companies, provision of data and statistics.</li> </ul> <p style="text-align: justify;">The calculations in the document are limited by data availability. The document is based on the NHIS (National Health Information System) database, CSSA (Czech Social Security Administration) data, AIFP’s internal data and publicly available data. <br /><strong>  <br /></strong><strong>We would like to thank all experts and participants, without whom it would have been impossible to make the study.<br />   </strong><strong><br /></strong>(Note: The calculated savings are indicative and should not be considered final results. The purpose of the document is not to verify the data provided.)</p> <div class="cleaner"></div> </div> </section> <footer> <div class="grid-container"> <div class="footerTop"> <div class="footerMenu"> <ul> <li><a href="/en/personal-data-processing-policy/">PERSONAL DATA PROCESSING POLICY</a></li> <li><a href="/en/download/">DOWNLOAD</a></li> </ul> </div> <a href="https://www.aifp.cz" target="_blank"><img alt="" src="/templates/custom_leky/img/logoFooter.png" /></a> </div> <div class="footerBottom"> <div class="copy">© 2024 All right reserved - všechna práva vyhrazena.</div> <div class="copyNeofema">© redakční systém <a href="http://www.kompletweb.cz/" target="_blank">Kompletweb</a>, © design <a href="http://www.neofema.cz" target="_blank">Neofema, s.r.o.</a></div> </div> </div> </footer> <img src="https://inovaceprozivot.cz/templates/custom_leky/img/defsharefb.jpg" style="display: none;" alt="" /> </div> <script type="text/javascript" src="/templates/custom_leky/js/jquery-2.2.5.min.js"></script> <script type="text/javascript" src="/templates/custom_leky/js/jquery.fancybox.min.js"></script> <script type="text/javascript" src="/templates/custom_leky/js/funkce.js?v=3"></script> <script type="text/javascript" src="/templates/custom_leky/js/script.js"></script> <script type="text/javascript" src="/templates/custom_leky/js/odometer.js"></script> <script type="text/javascript" src="/templates/custom_leky/js/odometer2.js?v=4"></script> <script type="text/javascript" src="/templates/custom_leky/js/swiper.min.js"></script> <script> $(document).ready(function () { var swiper = new Swiper('.swiper-container', { infinite: true, slidesToShow: 6, slidesToScroll: 1, arrows: false, autoplay: true, autoplaySpeed: 2000, speed: 2000, dots: false, pauseOnHover: true, pauseOnFocus: false, slidesPerView: 6, spaceBetween: 30, autoplay: true, autoplaySpeed: 2000, speed: 2000, dots: false, pauseOnHover: true, pauseOnFocus: false, pagination: { el: '.swiper-pagination', clickable: true, }, breakpoints: { 1024: { slidesPerView: 4, spaceBetween: 40, }, 768: { slidesPerView: 3, spaceBetween: 30, }, 640: { slidesPerView: 2, spaceBetween: 20, }, 380: { slidesPerView: 1, spaceBetween: 10, } }, responsive: [ { breakpoint: 1024, settings: { slidesToShow: 4, slidesToScroll: 4, infinite: true } }, { breakpoint: 767, settings: { slidesToShow: 3, slidesToScroll: 3, infinite: true } }, { breakpoint: 520, settings: { slidesToShow: 2, slidesToScroll: 2, infinite: true } }, { breakpoint: 400, settings: { slidesToShow: 1, slidesToScroll: 1, infinite: true } } ] }); $(".galerie").fancybox({ openEffect : 'elastic', closeEffect : 'elastic', helpers : { title : { type : 'inside' } } }); }); </script> </body> </html>